Antares Pharma Stock News

Today satellite rideshare launch provider Spaceflight Inc. announced its acquisition by Mitsui & Co., Ltd., in partnership with Yamasa Co., Ltd.,

Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Raymond

Russell Investments Group Ltd. boosted its stake in shares of Antares Pharma Inc (NASDAQ:ATRS) by 300.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities

‘Tis the season of spotting glow-in-the-dark clouds, so keep an eye open for those in the night sky

Lockdown has made many of us more enthusiastic about stargazing and there's a Strawberry Moon coming - this is how to see it

Less spectacular than a total eclipse but no less interesting, the penumbral lunar eclipse to be seen on Friday will be well worth watching

Cumberland finally has executed on its professed strategy of picking up approved drugs neglected by larger players. The problem is that the strategy hasn't nece

Why is a fast-growing company making one of the best testosterone replacement therapies on the market so underappreciated by investors?

Antares Pharma, Inc. (ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 10:00 a

Q1 2020 Antares Pharma Inc Earnings Call

May 25, 2020 (Market Insight Reports) -- The report presents an in-depth assessment of the Methotrexate Injection including enabling technologies, key...

Final earnings conference call transcript of Antares Pharma Inc. - ATRS stock

Q1 2020 Antares Pharma Inc Earnings Call